Johnson & Johnson reports that as of the end of 2014, the company faces 56,300 personal injury lawsuits for three products: metal hip implants, transvaginal mesh and the antipsychotic drug Risperdal. Several Risperdal lawsuits have recently gone to court, with multiple juries finding that the company failed to warn patients and doctors of the risks associated with Risperdal.
An Alabama man was awarded millions of dollars after a jury found that J&J was responsible for his gynecomastia due to Risperdal use. Gynecomastia is a condition in which young boys and male adolescents develop breast tissue. The 20-year old Alabama patient had taken Risperdal since he was 12 and eventually developed size DD breasts.
Johnson & Johnson may face more Risperdal lawsuits as boys and male adolescents come forward with complaints of breast tissue growth. Studies have found that the drug could indefinitely increase the levels of prolactin, a hormone responsible for breast tissue growth.
Patients are filing Risperdal lawsuits after the antipsychotic medication was linked to gynecomastia, or breast enlargement in male adolescents and children.
If you or a loved one experienced breast development after taking Risperdal, you may be eligible to file a lawsuit. Contact the lawyers at Hissey Kientz, LLP for a free case evaluation. You can reach us by calling toll-free at 1-866-275-4454, or by filling out our free contact form on the right of this page.